| ARHGEF7 |
IPI00449908 |
GIT2 |
IPI00238218 |
31.110 |
Evidence |
|
| RB1 |
RB1: Retinoblastoma-associated protein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
31.040 |
Evidence |
O
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
ARHGDIA |
ARHGDIA, GDIA1: Rho GDP-dissociation inhibitor 1 |
31.000 |
Evidence |
O
|
| CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
30.910 |
Evidence |
|
| CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
30.910 |
Evidence |
O
|
| CXCR4 |
CXCR4: C-X-C chemokine receptor type 4 |
JAK1 |
|
30.910 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
EP300 |
IPI00478752 |
30.290 |
Evidence |
|
| ERBB3 |
ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
30.160 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
GRB7 |
GRB7: Growth factor receptor-bound protein 7 |
30.160 |
Evidence |
|
| HLA-A |
HLA-A, HLAA: HLA class I histocompatibility antigen, A-3 alpha chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
30.080 |
Evidence |
O
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
30.080 |
Evidence |
|
| PRKAB2 |
PRKAB2: 5'-AMP-activated protein kinase subunit beta-2 |
PRKAG1 |
PRKAG1: 5'-AMP-activated protein kinase subunit gamma-1 |
30.070 |
Evidence |
O
|
| RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
30.020 |
Evidence |
O
|
| CD82 |
CD82, KAI1, SAR2, ST6, TSPAN27: CD82 antigen |
HLA-DMA |
DMA, HLA-DMA, DAQB-96B10.1-001, DASS-67H14.8-001, XXbac-BCX136A3.1-001, XXbac-BP |
30.020 |
Evidence |
O
|
| F10 |
F10: Coagulation factor X precursor |
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
29.770 |
Evidence |
O
|
| F2 |
F2: Prothrombin precursor |
THBD |
THBD, THRM: Thrombomodulin precursor |
29.770 |
Evidence |
O
|
| F2 |
F2: Prothrombin precursor |
PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
29.770 |
Evidence |
|
| ERCC2 |
ERCC2, XPD, XPDC: TFIIH basal transcription factor complex helicase subunit |
GTF2H2 |
GTF2H2, BTF2P44: TFIIH basal transcription factor complex p44 subunit |
29.680 |
Evidence |
O
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
UNG |
IPI00011069 |
29.590 |
Evidence |
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
INSR |
INSR: Insulin receptor precursor |
29.300 |
Evidence |
|
| CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
CAMKK1 |
IPI00166909 |
29.200 |
Evidence |
|
| EXOSC4 |
EXOSC4, RRP41, SKI6: Exosome complex exonuclease RRP41 |
KIAA1008 |
IPI00413548 |
29.100 |
Evidence |
|
| KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
28.920 |
Evidence |
|
| MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
DUSP6 |
DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 |
28.880 |
Evidence |
|
| SNAP23 |
SNAP23: Synaptosomal-associated protein 23 |
VAMP8 |
VAMP8: Vesicle-associated membrane protein 8 |
28.830 |
Evidence |
|
